A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
12/2002
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100413A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA
12/19/2002	WO2002100404A2 Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
12/19/2002	WO2002100386A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom
12/19/2002	WO2002058705A3 Degradation-resistant glucocorticosteroid formulations
12/19/2002	WO2001072977A9 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
12/19/2002	US20020193409 Prodrugs of anticancer agents employing substituted aromatic acids
12/19/2002	US20020193337 Gene therapy by secretory gland expression
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192285 Controlled release pellet formulation
12/19/2002	US20020192282 Multilayer pharmaceutical product for release in the colon
12/19/2002	US20020192216 Therapeutic use
12/19/2002	DE10127897A1 Combined pharmaceutical formulation for treating osteoporosis or related disorders, comprising core of dried plant extract enclosed in sheath of calcium salt
12/19/2002	CA2450366A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
12/19/2002	CA2448763A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert- butoxy carbonyl aminophenyl)ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a sulonylurea
12/19/2002	CA2447557A1 Using supercritical fluids to infuse therapeutic on a medical device
12/18/2002	EP1266659A1 Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
12/18/2002	EP1266014A2 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex
12/18/2002	EP1266012A2 Proteases
12/18/2002	EP1266001A2 Human transcription factors
12/18/2002	EP1265919A2 G-protein associated molecules
12/18/2002	EP1265911A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents
12/18/2002	EP1265899A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
12/18/2002	EP1265894A1 Crystalline form vii of cabergoline
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265838A1 Novel fatty acid analogous
12/18/2002	EP1265648A1 Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such
12/18/2002	EP1265617A2 Novel topical oestroprogestational compositions with systemic effect
12/18/2002	EP0946721B1 Human growth gene and short stature gene region
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	EP0789583B1 Methods and kits using macrophage stimulating protein
12/17/2002	US6495662 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
12/17/2002	US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
12/17/2002	US6495589 An amino acid derivative useful to increase secretion of growth hormone (gh) from the anterior pituitary of mammals, including on sustained release basis
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	CA2108977C Luteinizing hormone releasing hormone antagonist peptides
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002098863A1 Fused imidazole derivative
12/12/2002	WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	WO2002098452A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	WO2002098446A1 Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	WO2002098414A1 Methods using ptpase inhibitors and insulin
12/12/2002	WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002	WO2002098355A2 Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
12/12/2002	WO2002076494A3 USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
12/12/2002	WO2002074327A3 Compositions and methods for treating gonadotrophin related illnesses
12/12/2002	WO2002072078A3 Use of sugar phosphates, amino acids, amino acid analogs, e.g. carbomethoxypropionyl cyanide for reducing weight or diabetes complications
12/12/2002	WO2002064543A3 Novel succinate salt of o-desmethyl-venlafaxine
12/12/2002	WO2002064093A3 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
12/12/2002	WO2001092497A9 Human pancreatic islet glucose-6-phosphatase
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020187980 Methods using PTPase inhibitors and insulin
12/12/2002	US20020187973 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187970 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187969 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187968 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187967 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187966 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187965 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187964 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187963 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187962 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187938 Ghrelin antagonists
12/12/2002	US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B
12/12/2002	US20020187197 Templating of solid particles by polymer multilayers
12/12/2002	US20020187196 Capsules capsules actic-co-glycolic copolymer to which a citric ester plasticizer has been incorporated and which contain a peptide drug within them.
12/12/2002	CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2449320A1 Mixtures of growth hormone drug-oligomer conjugates compromising polyalkylene glycol, uses thereof, and methods of making same
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/11/2002	EP1264837A1 Conjugation-stabilized polypeptide compositions
12/11/2002	EP1263953A2 Novel family of mechanically sensitive human potassium channels activated by polyunsaturated fatty acids and use thereof
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263770A1 6-oxygenated steroidal estrogens with aromatic a and b rings
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263469A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues
12/11/2002	EP1263467A1 Improved paste formulations
12/11/2002	EP1263448A1 Maca and antler for augmenting testosterone levels
12/11/2002	EP1263444A2 Use of xanthine derivatives for preparing a medicine for preventing and treating osteoporosis
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263419A2 Compounds capable of binding with the cytoskeleton
12/11/2002	EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0937062B1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
12/11/2002	EP0937060B1 Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 290